Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer

AUSTIN, Texas, Nov. 30, 2022 -- (Healthcare Sales & Marketing Network) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metaboli... Biopharmaceuticals, Personnel Aeglea BioTherapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news